Pachychoroid disease spectrum has garnered considerable interest and has been discussed in detail in recent literature. It refers to a group of retinal and choroidal disorders, namely pigment epitheliopathy, central serous chorioretinopathy, neovasculopathy, and polypoid choroidal vasculopathy, all arising from a thickened choroid and hyperpermeable large choroidal vessels. We describe a case which had simultaneous presentation of multiple disorders on the pachychoroid spectrum. Multimodal findings in this patient have been described in this report. The presence of pachychoroid should prompt thorough imaging since coexistence of multiple disorders can potentially change the management and follow-up schedule of these patients.
Pachychoroid spectrum is being increasingly diagnosed, with its characteristic features being elucidated on spectral domain optical coherence tomography (SD-OCT), indocyanine green angiography (ICGA), and optical coherence tomography angiography (OCTA). We present a case that had simultaneous presentation of polypoidal choroidal vasculopathy, central serous chorioretinopathy (CSC), and pigment epitheliopathy, thus validating the pachychoroid spectrum of diseases.
Case Report
A 37-year-old male patient presented to us with complaints of decreased vision in the right eye (OD) for 1 week. Vision in the OD was 20/60 N36 and the left eye (OS) was 20/20 N6. Anterior segment evaluation was unremarkable. OD fundus revealed a large submacular hemorrhage with a diameter of 4 disc areas, with drusen superotemporal to the fovea [ A diagnosis of OD diffuse pachychoroid with polypoidal choroidal vasculopathy (PCV) and CSC was made. OS was diagnosed as a focal pachychoroid with PPE and PCV. Intravitreal aflibercept 2 mg/0.05 ml (Eylea, Regeneron Pharmaceuticals) was administered to the OD, following which there was resolution of subretinal hemorrhage and the height of the PED. The patient regained vision of 20/20, N6 in the OD at 3 months. He continues to be under 3-monthly follow-up and has maintained 20/20, N6 in the OS without any other complications due to pachychoroid.
Discussion
Pachychoroid describes a set of choroidal characteristics seen on SD-OCT as focal or diffuse choroidal thickening with larger outer choroidal vessels compressing the inner choroidal layers. On ICGA, large caliber vessels have been described that typically do not taper as they approach the posterior pole. [2] Access this article online This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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Case Reports
Pachychoroid is generally bilateral and can be incidentally detected with or without the disease manifestations. Genetic inheritance of pachychoroid was suggested by Lehmann et al. [3] Dansingani et al. studied 66 eyes of 33 patients and showed that pachychoroid leads to a spectrum of choroidal diseases, namely PPE, chronic serous chorioretinopathy (CSCR), pachychoroid neovasculopathy (PNV), and PCV; usually in chorological order. [4] In an eye with a hyperpermeable pachychoroid, PPE may result, if the retinal pigment epithelium (RPE) is able to overcome the choroidal congestion. If RPE fails to overcome 
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
the stress, there might be choriocapillaris damage and CSC as a result of RPE damage. Microrips in the Bruch's membrane may be seen along with the ischemic changes, leading to neovascular network, i.e., PNV. PCV finally develops in cases of long-standing PNV where there is aneurysmal dilation of the ends of the neovascular network. [5] It is hypothesized that the choroidal hyperpermeability and vascular congestion lead to the development of PCV and CSCR.
Manayath et al. demonstrate simultaneous PCV and CSC in 6 eyes associated with a dilated choroidal vessel on ICGA and hypothesized that both PCV and CSC are offshoots of the pachychoroid spectrum. [5] The mean age in their series was 62.6 years. Our report however is of a much younger patient with bilateral simultaneous presentation of all the disease manifestations of pachychoroid except PNV. We also utilized the enface feature of OCTA and were able to demonstrate a focal abnormality in the choroidal slab in the OS. Branching vascular network with polyps was also demonstrable in the OD on OCTA in our case.
Conclusion
Our findings add to the existing scant literature about the presence of the entire spectrum of pachychoroid in a single patient. We recommend regular follow-up of such patients to look for future recurrences of CSC, PNV, and PCV. These Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India 
Multimodal imaging of Bietti's crystalline dystrophy
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Bietti's crystalline dystrophy (BCD) is a rare autosomal recessive retinal dystrophy characterized by deposition of crystals in the retina. The purpose of this article is to describe retinal abnormalities in BCD using multimodal imaging. An 18-year-old girl presented with decrease of vision and nyctalopia. She was assessed with color fundus picture, red-free photographs, short-wave autofluorescence, spectral-domain optical coherence tomography (OCT) and en face OCT and was diagnosed to have BCD based on typical presentation. Retinal crystals were better visualized on en face OCT as compared to conventional B scan OCT.
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Autofluorescence, Bietti's crystalline dystrophy, en face imaging, multimodal, red-free photographs, spectral-domain optical coherence tomography Bietti's crystalline dystrophy (BCD) is a rare inherited retinal dystrophy, which usually presents with progressive visual loss in the third or fourth decade. [1] The disease is characterized by multiple small intraretinal crystal deposits. This causes retinal atrophy leading to peripheral visual field and visual loss often causing legal blindness by the fifth or sixth decade. [2] The crystalline deposits are seen throughout the body including lymphocytes and skin fibroblasts. [3] The gene responsible for BCD is cytochrome P450 4V2 (CYP4V2) which codes a protein involved in fatty acid metabolism. [4] We describe a case of BCD in a young girl using multimodal imaging highlighting the different aspects of disease with special emphasis on visibility of the characteristic retinal crystals.
